Photon8
- Company typePrivate
- Founded-
- HeadquartersCorpus Christi, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Photon8 does
Photon8 is a privately held industrial biotechnology company headquartered in Corpus Christi, Texas, developing algae-based production systems for lipids, proteins, and minerals. The company uses autotrophic photosynthesis to convert photons, CO2, and waste-stream nutrients into algae biomass, with near-term planned market entry in Omega-3 fatty acid products targeting the nutritional supplements and health products segment. Operations are physically anchored at Texas A&M University-Corpus Christi (TAMU-CC), where the company runs culturing facilities, lab-scale reactors, and outdoor production units, and are supplemented by a partnership with Louisiana State University for exclusive downstream processing technology. The company has been supported by the Shell GameChanger program, which enabled the buildout at TAMU-CC.
Photon8 firmographics
Firmographics- Name
- Photon8
- Legal name
- Photon8
- Website
- https://photon8.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Photon8 industry classification
Industry- Product category
- Algae-based biotechnology / Industrial biotech manufacturing
- NAICS
- Aquaculture (1125), Aquaculture (11251)
- akta.pro primary industry
- Seaweed & Algae Aquaculture (incl. microalgae) (AFAEAAAE)
- akta.pro secondary industries
- Biological CO₂ Utilization (algae/biotech conversion to fuels, chemicals, proteins) (EUABAIAJ), Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae) (AFAJAHAF)
Keywords
Where Photon8 is headquartered
LocationHeadquarters
- HQ city
- Corpus Christi
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Photon8 business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Infrastructure
Revenue model
- Omega-3 Products: Upcoming market entry focusing on Omega-3 production derived from algae biomass. The company is developing its commercial production capabilities ahead of launch.
- Algae Biomass Products: Products containing lipids, proteins, and minerals extracted from autotrophic algae through proprietary processes.
Go-to-market motion1 record
Marketing channels1 record
Photon8 product offering
Product offeringCore offering
Photon8 develops and operates an algae-based biotechnology platform that uses proprietary Parallel Film Reactor (PFR) systems with Traveling Wave Technology to cultivate autotrophic algae, converting photons, CO2, and nutrients into biomass rich in lipids, proteins, and minerals. The company pairs this with genetically enhanced algae strains and a chemical-free Aqueous Extraction process, with upcoming market entry focused on Omega-3 fatty acid production for nutritional supplements and broader sustainable-industry applications.
Product overview
Photon8 offers an integrated algae cultivation and processing system centered on its Parallel Film Reactor (PFR) technology with Traveling Wave Technology for closed-system algae growth, combined with genetically enhanced algae strains optimized for lipid production, and Aqueous Extraction for chemical-free lipid recovery. The company is positioning for market entry in Omega-3s, positioning itself as a sustainable alternative to conventional algae biofuels and omega-3 production approaches.
Differentiator
Problem solved
Functional benefit
Products and services
- Parallel Film Reactor (PFR) with Traveling Wave Technology Patent-pending closed algae cultivation system offering closed-system performance at under $10/m2, with full CO2 utilization and contamination resistance. Used by Photon8 and intended customers as the production backbone for algae-derived products.
- Aqueous Extraction Process Chemical-free water-based lipid extraction process that removes lipids from algae biomass without harsh chemicals, reducing extraction costs and preserving product purity. Applied to Photon8's algae-derived products.
- Genetically Enhanced Algae Strains Genetically enhanced algae strains engineered to produce lipids preferentially, decoupling lipid content from growth rate. Used as the biological feedstock within Photon8's cultivation system.
- Omega-3 Products (upcoming) Algae-derived Omega-3 fatty acid products intended for nutritional supplement and health-product manufacturers. Currently in pre-commercial preparation ahead of upcoming market entry.
- Algae Biomass Products (lipids, proteins, minerals) Algae biomass products containing lipids, proteins, and minerals produced via Photon8's autotrophic cultivation and chemical-free extraction platform, intended for sustainable-industry buyers across biofuels, agriculture, and carbon-capture applications.
Quantifiable outcome
- 100x reduction in capital and operating expenses compared to conventional algae biofuel approaches
- +2 more outcomes
Companies that use Photon8
Customer profileSegments2 records
Ideal customer profiles2 records
Photon8 technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Photon8 partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Texas A&M University-Corpus Christi (TAMU-CC)coreLongstanding partnership with Dr. Paul Zimba at TAMU-CC. The Shell GameChanger Project brought the company to TAMU-CC facilities which include culturing facilities, Lab PFRs, and extensive analytical equipment. Outdoor PFRs are producing on grounds ahead of upcoming Omega-3 market entry. The company enjoys extended staff through its relationship with TAMU-CC.
- Louisiana State University (LSU)corePartnership with LSU provides exclusive technology in downstream processing, adding to the unique and chemical-free nature of Photon8's products.
Scale indicators2 records
Recent moves6 records
Expansion highlights4 records
Photon8 competitors and assessment
Company assessmentEmerging players
- Cellana: Cellana is an algae biotechnology company developing phototrophic and heterotrophic algae strains for omega-3, biofuel, and bioproducts. It is directly comparable to Photon8 as a smaller-scale player building integrated algae cultivation and downstream processing.
- Checkerspot: Checkerspot is an algae-based biotechnology company that engineers proprietary strains to produce novel oils and ingredients (e.g., polyurethanes, performance ingredients). It overlaps with Photon8 in genetically enhanced algae strain development and oils commercialization.
- Synthetic Genomics: Synthetic Genomics (SGI) is a privately held synthetic biology company developing engineered algae and microbes for fuels, nutraceuticals, and industrial products. It is comparable to Photon8 as a fellow technology-led algae biotech venture pursuing multiple bio-product outputs.
Broad incumbents
- Cargill: Cargill is one of the largest agricultural and aquafeed ingredient suppliers globally, with active interests in sustainable omega-3 sourcing. It is both a potential offtake partner and competitor to Photon8 in algae-based feed ingredients and biofuels.
- Corbion: Corbion is a global ingredient and industrial biotech company that produces AlgaPrime DHA (algae-based omega-3) alongside a broad portfolio of food ingredients and biochemicals. It operates at commercial scale and competes broadly with Photon8 in the omega-3 and bio-based chemicals space.
- dsm-firmenich (Royal DSM): Royal DSM (now dsm-firmenich) is a major nutrition, health, and ingredients company with deep involvement in omega-3 via its Veramaris joint venture and broader nutrition portfolio. It is a major potential buyer/competitor for Photon8's algae-omega-3 output.
Others
- BASF: BASF is a global industrial chemicals and biotech company exploring fermentation- and algae-based routes to specialty chemicals, including omega-3 oils. It is an adjacent ecosystem participant and potential strategic partner/licensor for Photon8's bio-based specialty oils.
Direct peers
- Veramaris: Veramaris is a DSM/Marine Oil joint venture producing algae-based EPA & DHA omega-3 oils for aquafeed and nutrition. It is the most direct commercial competitor to Photon8's planned algae-omega-3 offering, serving the same end markets with the same algae-derived product.
- Mara Renewables: Mara Renewables develops and produces algae-based omega-3 oils (DHAgold, omega-3 DHA/EPA) from heterotrophic fermentation. It directly competes with Photon8 in algae-derived omega-3 for nutrition and aquafeed, with established commercial customers.
- BioVeritas: BioVeritas produces microbial (algae-derived) oils for omega-3 and oleochemical applications using proprietary strains and fermentation. It overlaps directly with Photon8 on single-cell oil and omega-3 platforms targeting food, feed, and biofuel markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Photon8 social profiles
Digital presencePhoton8 financial estimates
Financial estimateRevenue estimate
Valuation estimate
Photon8 leadership team
Management profileNumber of profiles
Photon8 funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Photon8 M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Photon8
What does Photon8 do?
Photon8 develops and operates an algae-based biotechnology platform that uses proprietary Parallel Film Reactor (PFR) systems with Traveling Wave Technology to cultivate autotrophic algae, converting photons, CO2, and nutrients into biomass rich in lipids, proteins, and minerals. The company pairs this with genetically enhanced algae strains and a chemical-free Aqueous Extraction process, with upcoming market entry focused on Omega-3 fatty acid production for nutritional supplements and broader sustainable-industry applications.
Is Photon8 a public or private company?
Photon8 is a private company. It is classified as venture growth investor backed and is currently operating.
When was Photon8 founded?
Photon8 was founded in -1. It employs 1 to 10 people.
Where is Photon8 based?
Photon8 is headquartered in Corpus Christi, United States, in the North America region.
How does Photon8 make money?
Two revenue lines are on record. Omega-3 Products are the primary driver. The others are algae Biomass Products.
Who are Photon8's main competitors?
Emerging players on record are Cellana, Checkerspot and Synthetic Genomics. Broad incumbents are Cargill, Corbion and dsm-firmenich (Royal DSM). BASF is listed as an others. Direct peers are Veramaris, Mara Renewables and BioVeritas.
Does Photon8 have an API?
No public API is recorded for Photon8.
What industry is Photon8 in?
Photon8's product category is Algae-based biotechnology / Industrial biotech manufacturing. Its primary akta.pro industry code is AFAEAAAE, Seaweed & Algae Aquaculture (incl. microalgae), with a secondary code of EUABAIAJ, Biological CO₂ Utilization (algae/biotech conversion to fuels, chemicals, proteins). Its NAICS code is 1125.